513
Views
20
CrossRef citations to date
0
Altmetric
Review Article

Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules

, &
Pages 513-523 | Received 04 Aug 2015, Accepted 27 Oct 2015, Published online: 25 Nov 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amandeep Godara, Nauman S. Siddiqui, Margaret M. Byrne & Muhammad Wasif Saif. (2019) The safety of lanreotide for neuroendocrine tumor. Expert Opinion on Drug Safety 18:1, pages 1-10.
Read now

Articles from other publishers (19)

Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto & Lorenzo Malatino. (2023) Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review. Journal of Clinical Medicine 12:20, pages 6617.
Crossref
A. La Salvia, R. Modica, R.E. Rossi, F. Spada, M. Rinzivillo, F. Panzuto, A. Faggiano, S. Cinieri & N. Fazio. (2023) Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists. Cancer Treatment Reviews 117, pages 102560.
Crossref
Sara Massironi, Camilla Gallo, Alice Laffusa, Cristina Ciuffini, Clara Benedetta Conti, Federico Barbaro, Ivo Boskoski, Marco Emilio Dinelli & Pietro Invernizzi. (2023) Endoscopic techniques for gastric neuroendocrine tumors: An update. World Journal of Gastrointestinal Endoscopy 15:3, pages 103-113.
Crossref
Krystallenia I. Alexandraki, Anna Angelousi, Eleftherios Chatzellis, Alexandra Chrisoulidou, Nikolaos Kalogeris, Georgios Kanakis, Christos Savvidis, Dimitra Vassiliadi, Ariadni Spyroglou, Georgios Kostopoulos, Vyron Markussis, Konstantinos Toulis, Stylianos Tsagarakis & Gregory A. Kaltsas. (2023) The Role of Somatostatin Analogues in the Control of Diarrhea and Flushing as Markers of Carcinoid Syndrome: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 13:2, pages 304.
Crossref
Feng Yin, Zi-Hao Wu & Jin-Ping Lai. (2022) New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastroenterology 28:17, pages 1751-1767.
Crossref
Camilla Gallo, Roberta Elisa Rossi, Federica Cavalcoli, Federico Barbaro, Ivo Boškoski, Pietro Invernizzi & Sara Massironi. (2022) Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance. World Journal of Gastroenterology 28:11, pages 1123-1138.
Crossref
Francesca Spada, Roberta E. Rossi, Elda Kara, Alice Laffi, Sara Massironi, Manila Rubino, Franco Grimaldi, Sherrie Bhoori & Nicola Fazio. (2021) Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals 14:6, pages 539.
Crossref
Mamiko Miyashita, Yoshihiro Ono, Manabu Takamatsu, Yosuke Inoue, Takafumi Sato, Hiromichi Ito, Yu Takahashi & Akio Saiura. (2020) Repeat hepatectomy for liver metastases from bile duct neuroendocrine tumor: a case report. Surgical Case Reports 6:1.
Crossref
Kivilcim ERDOGAN, İsa Burak GÜNEY, Gamze AKKUŞ, Ahmet RENCUZOGULLARİ, Hüsnü SÖNMEZ & Figen DORAN. (2020) Gastroenteropankreatik Nöroendokrin Tümörlerde Somatostatin Reseptörlerinin Önemi. Namık Kemal Tıp Dergisi.
Crossref
Roberta Elisa Rossi, Pietro Invernizzi, Vincenzo Mazzaferro & Sara Massironi. (2020) Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysis. United European Gastroenterology Journal 8:2, pages 140-147.
Crossref
Margarita Ptasnuka, Arturs Ozolins, Zenons Narbuts, Arturs Truskovs, Maris Sperga & Haralds Plaudis. (2019) Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia. World Journal of Surgery 44:2, pages 585-593.
Crossref
Ilias P Papakonstantinou, Nikolaos D Karakousis & Emmanouel A Andreadis. (2019) Gastric neuroendocrine tumour, atrophic gastritis and autoimmune haemolytic anaemia: a case report and review. Scottish Medical Journal 64:4, pages 154-158.
Crossref
Sara Pusceddu, Natalie Prinzi, Alessandra Raimondi, Francesca Corti, Roberto Buzzoni, Maria Di Bartolomeo, Ettore Seregni, Marco Maccauro, Jorgelina Coppa, Massimo Milione, Vincenzo Mazzaferro & Filippo de Braud. (2018) Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge. Tumori Journal 105:2, pages 113-120.
Crossref
Elizaveta Fisher, Kirill Pavlenko, Alexander Vlasov & Galina Ramenskaya. (2019) Peptide-Based Therapeutics for Oncology. Pharmaceutical Medicine 33:1, pages 9-20.
Crossref
Aura D. Herrera-Martínez, Manuel D. Gahete, Rafael Sánchez-Sánchez, Emilia Alors-Perez, Sergio Pedraza-Arevalo, Raquel Serrano-Blanch, Antonio J. Martínez-Fuentes, Maria A. Gálvez-Moreno, Justo P. Castaño & Raúl M. Luque. (2018) Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors. Clinical and Translational Gastroenterology 9:10, pages e196.
Crossref
Ruben Mujica-Mota, Jo Varley-Campbell, Irina Tikhonova, Chris Cooper, Ed Griffin, Marcela Haasova, Jaime Peters, Stefano Lucherini, Juan Talens-Bou, Linda Long, David Sherriff, Mark Napier, John Ramage & Martin Hoyle. (2018) Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis. Health Technology Assessment 22:49, pages 1-326.
Crossref
Wouter W. de Herder. (2018) When and How to Use Somatostatin Analogues. Endocrinology and Metabolism Clinics of North America 47:3, pages 549-555.
Crossref
Terry W. Moody, Irene Ramos-Alvarez & Robert T. Jensen. (2018) Neuropeptide G Protein-Coupled Receptors as Oncotargets. Frontiers in Endocrinology 9.
Crossref
Elettra Merola, Francesco Panzuto & Gianfranco Delle Fave. (2017) Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Oncotarget 8:28, pages 46624-46634.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.